Arteriosclerosis D001161

Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Arterial Occlusive Diseases » Arteriosclerosis

Description

Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.   MeSH

Subtype Terms (6)

Arteriolosclerosis
 

Arteriosclerosis Obliterans
5 drugs (3 approved, 2 experimental)

Atherosclerosis
258 drugs (148 approved, 110 experimental)

Coronary Artery Disease
410 drugs (236 approved, 174 experimental)

Intermittent Claudication
52 drugs (25 approved, 27 experimental)

Intracranial Arteriosclerosis
24 drugs (20 approved, 4 experimental)


Approved Indicated Drugs (1)

Phase 3 Indicated Drugs (1)

Other Experimental Indicated Drugs (4)


Organization Involved with Phase 4 Indications (59)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.